Gallium-68 Market

Gallium-68 Market (Application: Oncology, Cardiology, Neurology, and Others; and End User: Hospitals, Diagnostic Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Ga-68 Holds Potential to Explore Several Diagnostic Imaging Applications

Gallium-68 (Ga-68, 68Ga) is a positron-emitting radioisotope that is created from a 68Ge/68Ga generator. It has a half-life of 68 minutes, and is popular for its application as a radiopharmaceutical tracer used during PET scans. The introduction of PSMA-targeting tracers such as the PSMA-11, PSMA-617, and PSMA-I&T has increased the clinical utilization of 68Ga-radiopharmaceuticals for diagnostic imaging. The constantly growing applications of gallium-68 radiopharmaceuticals have gained increased attention in recent years. Gallium-68, when combined with lutetium-177 (Lu-177), allows diagnostic molecular imaging followed by the customized treatment based on the diagnostic scan. This method has proven to be more efficient for the treatment of neuroendocrine tumors (NETs) using the peptide receptor radionuclide therapy (PRRT). Studies suggest that more than 12,000 people in the U.S. are treated with neuroendocrine tumors each year. Thus, efforts are made to spread the information and data throughout the healthcare segments to enhance the results and studies. The growing awareness about NETs as well as advancements in nuclear medicine is expected to boost the gallium-68 market during the forecast period.

Presently, gallium-68 is most extensively utilized in the analysis of prostate cancer in the form of 68Ga, Ga-PSMA-11, respectively. The combination of Ga-68 and Lu-177 forms a theranostic pair, which is demonstrably effective for the treatment and diagnosis of prostate cancer, as the 68Ga/177Lu-radiolabelled tracers show a very similar biological behavior. Moreover, one of the market influencing applications of Ga-86-based radiopharmaceuticals is the labeling of human epidermal growth factor receptor family (HER2) and carcinoembryonic antigen (CEA). This is likely to improve the position of the global gallium-68 market. Furthermore, gallium-68 is a very helpful radionuclide for use in radiopharmacy. Moreover, it is popular in radiopharmaceuticals compared to other diagnostic isotopes. The usability and the commercial availability of generators simplified research and motivated developments with a view to a broad routine application.

gallium 68 market infographic

Request a sample to get extensive insights into the Gallium-68 Market

Oncology, Neurology Segments Came to Halt During Pandemic

The COVID-19 pandemic has had a profound impact on imaging practices across the country, which, in turn, influenced the decline in the demand for gallium-68. Stringent regulations for the global supply chain and trade of raw materials to limit the transmission of coronavirus are affecting the gallium-68 market in imaging applications. The globally available healthcare facilities have expanded their intake capacity for COVID-19 patients, which resulted in an unsafe ambiance for other imaging patients. Financial recessions usually tend to result in reduced healthcare investments; however, radiology practices have barely experienced any economic collapse that is concurrently intensified by the need to restrict the availability of imaging until the COVID-19 pandemic. The outpatient-heavy practices had the biggest impact on these changes, but all imaging volumes decreased. Nevertheless, various healthcare relief organizations are helping to provide several means of direct and indirect aid to healthcare providers and small businesses.

The actual impression that COVID-19 has had on the medical imaging industry with gallium-68 applications remains to be perceived, as hospitals and imaging facilities endeavor to figure out the post-COVID-19 era strategies, as nonessential imaging diagnosis and procedures were postponed. The professionals are deciding on new business models to restore the pending diagnosis and smoothly run the practices as before COVID-19. This is likely to create new opportunities for the gallium-68 market in the upcoming future. Moreover, the rapid progress in the COVID-19 vaccine distribution and upgrades in healthcare facilities ensure to open the market very shortly. The global gallium-68 market is expected to grow post-COVID-19 owing to several imagining and healthcare applications.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Enhanced Research on Applications of Gallium-68 Reveals New Opportunities

The applications of gallium-68 are emerging in nuclear medicine, due to its cyclotron-independency and availability via radionuclide generator. The detailed research and studies on gallium-68 resulted in the advancements of generator design facilitated research on new 68Ga-radiopharmaceuticals as well as the clinical use of the known. In addition, the gallium-68-labeled peptides have been identified as a unique class of radiopharmaceuticals dispensing fast target localization and blood clearance. The (68)Ga-Dototatoc, (8)Ga-Dotatate, (68)Ga-Dotanoc are the most popular radiopharmaceuticals currently in use for imaging and separating lesions of various somatostatin receptor subtypes, overexpressed in many neuroendocrine tumors.

Despite Ga-68 being available for more than three decades of research, its uses for clinical PET have recently emerged, and only now is it being applied to pre-clinical models of human disease. Moreover, other applications such as the Ga-67-citrate continue to be extensively used radiopharmaceutical for the clinical diagnosis of specific types of neoplasms, such as Hodgkin’s disease, lung cancer, non-Hodgkin’s lymphoma, malignant melanoma, and leukemia.

Asia Pacific to Offer Lucrative Opportunities to Gallium-68 Market

The Asia Pacific region is witnessing constant economic growth, improved healthcare facilities, rise in consumer awareness and incomes, and increase in the significance of nuclear medicine in numerous medical disciplines, including cardiology, oncology, and endocrinology. Moreover, there is an extended use with the potential to offer significant opportunities for gallium-68 in developing economies including China and India. Accordingly, major businesses and market players plan to invest and expand business in these countries. These players are adopting inorganic growth strategies to boost the global gallium-68 market during the forecast period. However, rise in access to healthcare and rapid introduction of advanced technological implementations in PET systems in North America are likely to result in the region’s dominance of the gallium-68 market.

On the contrary, the rising use of gallium-68 radiopharmaceuticals in the diagnosis of diseases related to cardiology, respiratory, and urology is anticipated to drive the gallium-68 market in Europe. Due to several such factors, the global gallium-68 market is projected to reach US$ 200 Mn by 2031, expanding at a CAGR of ~8% from 2021 to 2031.

gallium 68 market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Gallium-68 Market

Analysts’ Viewpoint

The rise in the prevalence of tumors and cancer has led to the growth in the demand for gallium-68, as radioisotopes in clinical PET imaging facilities are routines used. This is a major factor driving the demand for gallium-68. Gallium-68 has a growing influence in molecular imaging by positron emission tomography, owing to the easy availability from 68Ge/68Ga generator and cyclotrons, good radiation properties, and rich Ga3+ coordination chemistry. Thus, the rising utilization of gallium-68 based tracer in PET is expected to drive the global gallium-68 market. Furthermore, there is ongoing research activities by various businesses for several new applications of Ga-68, which can potentially create new and better opportunities for the global market. Additionally, newer 68Ga-labeled tracers are being examined for various therapeutic applications and in nuclear imaging. This is expected to propel the global gallium-68 market during the forecast period.

Gallium-68 Market: Overview

  • This report analyzes the current scenario and future prospects of the global gallium-68 market. Rise in prevalence of oncology and cardiovascular diseases, and increase in preference for PET/CT scans using gallium-68 based isotopes for different indications are projected to boost the global gallium-68 market.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global gallium-68 market. It also provides information and data analysis of the gallium-68 market about segments based on application, end user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global gallium-68 market
  • The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global gallium-68 market
  • The report on the gallium-68 market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global gallium-68 market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global gallium-68 market.

Gallium-68 Market: Key Segments

  • In terms of application, the global gallium-68 market has been classified into oncology, cardiology, neurology, and others. The oncology segment accounted for a major share of the market in 2020, and the trend is anticipated to continue during the forecast period. Rise in the number of cancer patients globally, and increase in awareness about cancer diseases and advanced PET technologies are key factors fueling the segment.
  • Based on end user, the global gallium-68 market has been categorized into hospitals, diagnostic centers, and others. The hospitals segment dominated the market in 2020. This can be attributed to high procedural volume of medical imaging procedures at these institutions and higher efficiency of handling sensitive radio nucleotides such as gallium-68 at these locations.
  • Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year.

Gallium-68 Market: Regional Outlook

  • In terms of region, the global gallium-68 market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The gallium-68 market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The gallium-68 market study also covers the competitive scenario in these regions.

Companies Covered in Gallium-68 Market Report

  • Key players in the global gallium-68 market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the gallium-68 market report are
    • Siemens Healthineers AG
    • ITM Isotopen Technologien München AG
    • Advanced Accelerator Applications (a Novartis AG Company)
    • Telix Pharmaceuticals

Gallium-68 Market – Segmentation

Application
  • Oncology
  • Cardiology
  • Neurology
  • Others
End User
  • Hospitals
  • Diagnostic Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of gallium-68 market?

Gallium-68 market was valued at ~US$ 100 Mn in 2020 and is projected to reach US$ 200 Mn by 2031

What is the anticipated CAGR of the gallium-68 market in the forecast period?

Gallium-68 market is projected to expand at a CAGR of ~8% from 2021 to 2031

What are the key driving factors for the growth of the gallium-68 market?

Gallium-68 market is driven by growing awareness about NETs as well as advancements in nuclear medicine

Which is the rising prominent segment in the gallium-68 market?

The oncology segment accounted for a major share of the market, and the trend is anticipated to continue during the forecast period

Who are the key players in the global gallium-68 market?

Key players in the global gallium-68 market include Siemens Healthineers AG, ITM Isotopen Technologien München AG, Advanced Accelerator Applications (a Novartis AG Company), Telix Pharmaceuticals

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Gallium-68 Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Gallium-68 Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Health Care Industry Overview 

        5.2. Radioactive Material Transport Guidelines

        5.3. Radiation Protection Guidelines

        5.4. Installed PET Scanner Base Data, by Region

        5.5. Number of PET/CT Scan, by Regions (2019)

        5.6. FDA Approved Radiopharmaceuticals Products

        5.7. PET Drug Workflow

        5.8. Number of Radiotherapy Center: by Major Countries

        5.9. Clinical Trials for Gallium-68 Radioisotope

        5.10. COVID-19 Impact Analysis

    6. Global Gallium-68 Market Analysis and Forecast, by Application 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Gallium-68 Market Value Forecast, by Application, 2017–2031

            6.3.1. Hospitals

            6.3.2. Diagnostic Centers

            6.3.3. Others

        6.4. Global Gallium-68 Market Attractiveness, by Application 

    7. Global Gallium-68 Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Gallium-68 Market Value Forecast, by Application, 2017–2031

            7.3.1. Oncology 

            7.3.2. Cardiology

            7.3.3. Neurology

            7.3.4. Others

        7.4. Global Gallium-68 Market Attractiveness, by Application 

    8. Global Gallium-68 Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Gallium-68 Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. Global Gallium-68 Market Attractiveness, by Country/Region

    9. North America Gallium-68 Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Gallium-68 Market Value Forecast, by Application, 2017–2031

            9.2.1. Hospitals

            9.2.2. Diagnostic Centers

            9.2.3. Others

        9.3. North America Gallium-68 Market Value Forecast, by Application, 2017–2031

            9.3.1. Oncology 

            9.3.2. Cardiology

            9.3.3. Neurology

            9.3.4. Others

        9.4. North America Gallium-68 Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Gallium-68 Market Attractiveness Analysis 

            9.5.1. By Application 

            9.5.2. By Application 

            9.5.3. By Country

    10. Europe Gallium-68 Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Gallium-68 Market Value Forecast, by Application, 2017–2031

            10.2.1. Hospitals

            10.2.2. Diagnostic Centers

            10.2.3. Others

        10.3. Europe Gallium-68 Market Value Forecast, by Application, 2017–2031

            10.3.1. Oncology 

            10.3.2. Cardiology

            10.3.3. Neurology

            10.3.4. Others

        10.4. Europe Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Europe Gallium-68 Market Attractiveness Analysis 

            10.5.1. By Application 

            10.5.2. By Application 

            10.5.3. By Country/Sub-region

    11. Asia Pacific Gallium-68 Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Gallium-68 Market Value Forecast, by Application, 2017–2031

            11.2.1. Hospitals

            11.2.2. Diagnostic Centers

            11.2.3. Others

        11.3. Asia Pacific Gallium-68 Market Value Forecast, by Application, 2017–2031

            11.3.1. Oncology 

            11.3.2. Cardiology

            11.3.3. Neurology

            11.3.4. Others

        11.4. Asia Pacific Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Asia Pacific Gallium-68 Market Attractiveness Analysis 

            11.5.1. By Application 

            11.5.2. By Application 

            11.5.3. By Country/Sub-region

    12. Latin America Gallium-68 Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Gallium-68 Market Value Forecast, by Application, 2017–2031

            12.2.1. Hospitals

            12.2.2. Diagnostic Centers

            12.2.3. Others

        12.3. Latin America Gallium-68 Market Value Forecast, by Application, 2017–2031

            12.3.1. Oncology 

            12.3.2. Cardiology

            12.3.3. Neurology

            12.3.4. Others

        12.4. Latin America Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Latin America Gallium-68 Market Attractiveness Analysis 

            12.5.1. By Application 

            12.5.2. By Application 

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Gallium-68 Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Gallium-68 Market Value Forecast, by Application, 2017–2031

            13.2.1. Hospitals

            13.2.2. Diagnostic Centers

            13.2.3. Others

        13.3. Middle East & Africa Gallium-68 Market Value Forecast, by Application, 2017–2031

            13.3.1. Oncology 

            13.3.2. Cardiology

            13.3.3. Neurology

            13.3.4. Others

        13.4. Middle East & Africa Gallium-68 Market Value Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Gallium-68 Market Attractiveness Analysis 

            13.5.1. By Application 

            13.5.2. By Application 

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Company Profiles

            14.1.1. Siemens Healthineers AG

                14.1.1.1. Company Overview

                14.1.1.2. Company Financials

                14.1.1.3. Growth Strategies

                14.1.1.4. SWOT Analysis

            14.1.2. ITM Isotopen Technologien München AG

                14.1.2.1. Company Overview

                14.1.2.2. Company Financials

                14.1.2.3. Growth Strategies

                14.1.2.4. SWOT Analysis

            14.1.3. Advanced Accelerator Applications (a Novartis AG Company)

                14.1.3.1. Company Overview

                14.1.3.2. Company Financials

                14.1.3.3. Growth Strategies

                14.1.3.4. SWOT Analysis

            14.1.4. Telix Pharmaceuticals

                14.1.4.1. Company Overview

                14.1.4.2. Company Financials

                14.1.4.3. Growth Strategies

                14.1.4.4. SWOT Analysis

    List of Tables

    Table 1: Health Care Industry Overview 

    Table 2: North America Installed Base

    Table 3: Europe Installed Base 

    Table 4: Europe Installed Base

    Table 5: Asia –Pacific Installed Base 

    Table 6: ROW Installed Base 

    Table 7: Number of PET/CT Scan by Continent

    Table 8: Number of PET/CT Scan Performed in Asia

    Table 9: Number of PET/CT Scan Performed in Eastern Europe and Northern Asia

    Table 10: Number of PET/CT Scan Performed in Latin America & Caribbean

    Table 11: Number of PET/CT Scan Performed in Middle East

    Table 12: Number of PET/CT Scan Performed in Africa

    Table 13: Number of PET/CT Scan Performed in High-income Countries (2018)

    Table 14: FDA Approved Radiopharmaceuticals Products

    Table 15: FDA Approved Radiopharmaceuticals Products

    Table 16: FDA Approved Radiopharmaceuticals Products

    Table 17: Number of Radiotherapy Centers, by Country

    Table 18: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 19: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 20: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 21: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 22: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 23: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 24: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 25: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 26: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 27: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 28: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 29: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 30: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 31: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 32: Clinical trials involving the use of 68Ga radiopharmaceutical

    Table 33: Global Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 34: Global Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 35: Global Gallium-68 Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 36: North America Gallium-68 Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 37: North America Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 38: North America Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 39: Europe Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 40: Europe Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 41: Europe Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 42: Asia Pacific Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 43: Asia Pacific Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 44: Asia Pacific Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 45: Latin America Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 46: Latin America Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 47: Latin America Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 48: Middle East & Africa Gallium-68 Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 49: Middle East & Africa Gallium-68 Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 50: Middle East & Africa Gallium-68 Market Value (US$ Mn) Forecast, by Application, 2017–2031

    List of Figure

    Figure 01: Global Gallium-68 Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 02: Global Gallium-68 Market Value Share, by Region, 2020

    Figure 03: PET Drug Workflow

    Figure 04: Global Gallium-68 Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 05: Global Gallium-68 Market Value (US$ Mn), by Hospitals, 2017–2031

    Figure 06: Global Gallium-68 Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

    Figure 07: Global Gallium-68 Market Value (US$ Mn), by Others, 2017–2031

    Figure 08: Global Gallium-68 Market Attractive Analysis, by End-user, (2021-2031)

    Figure 09: Global Gallium-68 Market Value Share Analysis, by Application, 2020 and 2031

    Figure 10: Global Gallium-68 Market Attractiveness Analysis, by Application, 2021–2031

    Figure 11: Global Gallium-68 Market Value (US$ Mn), by Oncology, 2017–2031

    Figure 12: Global Gallium-68 Market Value (US$ Mn), by Cardiology , 2017–2031

    Figure 13: Global Gallium-68 Market Value (US$ Mn), by Neurology, 2017–2031

    Figure 14: Global Gallium-68 Market Value (US$ Mn), by Others, 2017–2031

    Figure 15: Global Gallium-68 Market Value Share Analysis, by Region, 2020 and 2031

    Figure 16: Global Gallium-68 Market Attractiveness Analysis, by Region, 2021–2031

    Figure 17: North America Gallium-68 Market Value (US$ Mn) Forecast, 2017–2031

    Figure 18: North America Gallium-68 Market Value Share Analysis, by Country, 2020 and 2031

    Figure 19: North America Gallium-68 Market Attractiveness Analysis, by Country, 2021–2031

    Figure 20: North America Gallium-68 Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 21: North America Gallium-68 Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 22: North America Gallium-68 Market Value Share Analysis, by Application, 2020 and 2031

    Figure 23: North America Gallium-68 Market Attractiveness Analysis, by Application, 2021–2031

    Figure 24: Europe Gallium-68 Market Value (US$ Mn) Forecast, 2017–2031

    Figure 25: Europe Gallium-68 Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 26: Europe Gallium-68 Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 27: Europe Gallium-68 Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 28: Europe Gallium-68 Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 29: Europe Gallium-68 Market Value Share Analysis, by Application, 2020 and 2031

    Figure 30: Europe Gallium-68 Market Attractiveness Analysis, by Application, 2021–2031

    Figure 31: Asia Pacific Gallium-68 Market Value (US$ Mn) Forecast, 2017–2031

    Figure 32: Asia Pacific Gallium-68 Market Value Share Analysis, by Country, 2020 and 2031

    Figure 33: Asia Pacific Gallium-68 Market Attractiveness Analysis, by Country, 2021–2031

    Figure 34: Asia Pacific Gallium-68 Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 35: Asia Pacific Gallium-68 Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 36: Asia Pacific Gallium-68 Market Value Share Analysis, by Application, 2020 and 2031

    Figure 37: Asia Pacific Gallium-68 Market Attractiveness Analysis, by Application, 2021–2031

    Figure 38: Latin America Gallium-68 Market Value (US$ Mn) Forecast, 2017–2031

    Figure 39: Latin America Gallium-68 Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 40: Latin America Gallium-68 Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 41: Latin America Gallium-68 Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 42: Latin America Gallium-68 Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 43: Latin America Gallium-68 Market Value Share Analysis, by Application, 2020 and 2031

    Figure 44: Latin America Gallium-68 Market Attractiveness Analysis, by Application, 2021–2031

    Figure 45: Middle East & Africa Gallium-68 Market Value (US$ Mn) Forecast, 2017–2031

    Figure 46: Middle East & Africa Gallium-68 Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 47: Middle East & Africa Gallium-68 Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 48: Middle East & Africa Gallium-68 Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 49: Middle East & Africa Gallium-68 Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 50: Middle East & Africa Gallium-68 Market Value Share Analysis, by Application, 2020 and 2031

    Figure 51: Middle East & Africa Gallium-68 Market Attractiveness Analysis, by Application, 2021–2031

    Figure 52: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 53: Breakdown of Net Sales (%), by Region, 2020

    Figure 54: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 55: Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 56: Revenue (US$ Thousand) and Y-o-Y Growth (%), 2018–2020

    Figure 57: R&D Expenses (US$ Thousands) and Y-o-Y Growth (%), 2017–2020

Copyright © Transparency Market Research, Inc. All Rights reserved